Effects of substrate-free anoxia and veratridine on intracellular calcium concentration in isolated rat ventricular cardiomyocytes.
Cytosolic free Ca2+ concentration ([Ca2+]i) was measured in freshly isolated rat ventricular cardiomyocytes during substrate-free anoxia. Cardiomyocytes were loaded with fura-2 and incubated in an anoxic chamber in which a pO2 equal to 0 mmHg was realized by inclusion of Oxyrase. [Ca2+]i was measured in individual cells using digital imaging fluorescence microscopy. During anoxia, the shape of cardiomyocytes changed from a relaxed-elongated form into a rigor configuration within 15 min after the onset of anoxia. After the cells had developed the rigor state, a delayed rise in [Ca2+]i reached a stable maximal level within 45 min. The mean values for the pre-anoxic and maximal anoxic [Ca2]i were 52 +/- 3 nM (N = 42) and 2115 +/- 59 nM (N = 45), respectively. The purported Na+ overload blocker R 56865, significantly reduced maximal anoxic [Ca2+]i to 533 +/- 56 nM (P < 0.05), implicating a role of elevated intracellular Na+ in the anoxia-induced increase in [Ca2+]i. Veratridine (30 microM), with induces Na+ overload, increased [Ca2+]i to 787 +/- 39 nM. The compound R 56865 reduced veratridine-induced increases in [Ca2+]i to 152 +/- 38 nM. Upon reperfusion, after 45 min of anoxia, two distinct responses were observed. Most often, [Ca2+]i decreased upon reperfusion without a change in morphology or viability, while in the minority of cases, [Ca2+]i increased further followed by hypercontraction and loss of cell viability. The mean value for [Ca2+]i 10 min after reperfusion of the former group, was 752 +/- 46 nM (N = 38).(ABSTRACT TRUNCATED AT 250 WORDS)
Rose
U M
UM
Department of Cell Physiology, University of Nijmegen, The Netherlands.
Couwenberg
P
P
Jansen
J W
JW
Bindels
R J
RJ
Van Os
C H
CH
D000818:Animals; D052160:Benzothiazoles; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000494:pharmacology; D015687:Cell Hypoxia / Q000502:physiology*; D002469:Cell Separation; D048429:Cell Size / Q000187:drug effects; D008297:Male; D008856:Microscopy, Fluorescence; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000166:cytology / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012964:Sodium / Q000378:metabolism; D013844:Thiazoles / Q000494:pharmacology; D014701:Veratridine / Q000494:pharmacology*
D052160:Benzothiazoles; D002121:Calcium Channel Blockers; D010880:Piperidines; D013844:Thiazoles; D014701:Veratridine; C054551:R 56865; D012964:Sodium; D002118:Calcium